Cargando…
Radiofrequency Ablation of Parathyroid Glands to Treat a Patient With Hypercalcemia Caused by a Novel Inactivating Mutation in CaSR
OBJECTIVE: We identified a novel inactivating mutation in the calcium-sensing receptor (CaSR) gene in a patient with refractory hypocalciuric hypercalcemia and analyzed its function. The effectiveness of radiofrequency ablation of the parathyroid glands to treat hypercalcemia caused by this mutation...
Autores principales: | Hao, Yu, Lei, Zhikai, Shi, Nanjing, Yu, Lingying, Ji, Weiqin, Zhang, Xianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795859/ https://www.ncbi.nlm.nih.gov/pubmed/35095753 http://dx.doi.org/10.3389/fendo.2021.743517 |
Ejemplares similares
-
An Unusual Case of Meningioma Showing Increased CaSR Expression with Parathyroid Carcinoma
por: Yoo, Jin Sae, et al.
Publicado: (2018) -
Physiological studies in heterozygous calcium sensing receptor (CaSR) gene-ablated mice confirm that the CaSR regulates calcitonin release in vivo
por: Fudge, Neva J, et al.
Publicado: (2004) -
SAT-350 A Tale of Two Mutations: Familial Hypocalciuric Hypercalcemia Caused by a Novel CaSR Start Codon Mutation Found in the Setting of a CaSR Hypercalciuric Variant
por: Bandaru, Sindhura, et al.
Publicado: (2020) -
A novel CaSR mutation presenting as a severe case of neonatal familial hypocalciuric hypercalcemia
por: Tonyushkina, Ksenia N, et al.
Publicado: (2012) -
Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused by biased allosteric CaSR autoantibodies
por: Makita, Noriko, et al.
Publicado: (2022)